|Targeting prodromal Alzheimer disease with avagacestat: a randomized clinical trial|
V Coric, S Salloway, CH van Dyck, B Dubois, N Andreasen, M Brody, ...
JAMA neurology 72 (11), 1324-1333, 2015
|Unmet needs of caregivers of individuals referred to a dementia care program|
LA Jennings, DB Reuben, LC Evertson, KS Serrano, L Ercoli, J Grill, ...
Journal of the American Geriatrics Society 63 (2), 282-289, 2015
|Transient analgesia evoked by noxious stimulus offset|
JD Grill, RC Coghill
Journal of neurophysiology 87 (4), 2205-2208, 2002
|Age-related and laminar-specific dendritic changes in the medial frontal cortex of the rat|
JD Grill, DR Riddle
Brain research 937 (1-2), 8-21, 2002
|Current therapeutic targets for the treatment of Alzheimer’s disease|
JD Grill, JL Cummings
Expert review of neurotherapeutics 10 (5), 711-728, 2010
|Addressing the challenges to successful recruitment and retention in Alzheimer's disease clinical trials|
JD Grill, J Karlawish
Alzheimer's research & therapy 2 (6), 34, 2010
|Development of a process to disclose amyloid imaging results to cognitively normal older adult research participants|
K Harkins, P Sankar, R Sperling, JD Grill, RC Green, KA Johnson, ...
Alzheimer's research & therapy 7 (1), 1-9, 2015
|Facilitating Alzheimer’s disease research recruitment|
JD Grill, JE Galvin
Alzheimer disease and associated disorders 28 (1), 1, 2014
|Estimating sample sizes for predementia Alzheimer's trials based on the Alzheimer's Disease Neuroimaging Initiative|
JD Grill, L Di, PH Lu, C Lee, J Ringman, LG Apostolova, N Chow, ...
Neurobiology of aging 34 (1), 62-72, 2013
|African Americans are less likely to enroll in preclinical Alzheimer's disease clinical trials|
Y Zhou, D Elashoff, S Kremen, E Teng, J Karlawish, JD Grill
Alzheimer's & Dementia: Translational Research & Clinical Interventions 3 (1 …, 2017
|Effect of study partner on the conduct of Alzheimer disease clinical trials|
JD Grill, R Raman, K Ernstrom, P Aisen, J Karlawish
Neurology 80 (3), 282-288, 2013
|Communicating mild cognitive impairment diagnoses with and without amyloid imaging|
JD Grill, LG Apostolova, S Bullain, JM Burns, CG Cox, M Dick, D Hartley, ...
Alzheimer's research & therapy 9 (1), 35, 2017
|Novel targets for Alzheimer's disease treatment|
JD Grill, JL Cummings
Expert review of neurotherapeutics 10 (5), 711, 2010
|Multilocus genetic profiling to empower drug trials and predict brain atrophy|
O Kohannim, X Hua, P Rajagopalan, DP Hibar, N Jahanshad, JD Grill, ...
NeuroImage: Clinical 2, 827-835, 2013
|Risk disclosure and preclinical Alzheimer’s disease clinical trial enrollment|
JD Grill, J Karlawish, D Elashoff, BG Vickrey
Alzheimer's & Dementia 9 (3), 356-359. e1, 2013
|Why are spousal caregivers more prevalent than nonspousal caregivers as study partners in AD dementia clinical trials?|
MS Cary, JD Rubright, JD Grill, J Karlawish
Alzheimer disease and associated disorders 29 (1), 70, 2015
|Should we disclose amyloid imaging results to cognitively normal individuals?|
JD Grill, DK Johnson, JM Burns
Neurodegenerative disease management 3 (1), 43-51, 2013
|Critical review of the appropriate use criteria for amyloid imaging: effect on diagnosis and patient care|
LG Apostolova, JM Haider, N Goukasian, GD Rabinovici, G Chételat, ...
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 5, 15-22, 2016
|Willingness to be a brain donor: a survey of research volunteers from four racial/ethnic groups|
L Boise, L Hinton, HJ Rosen, M Ruhl, H Dodge, N Mattek, M Albert, ...
Alzheimer disease and associated disorders 31 (2), 135, 2017
|Alzheimer’s disease progression by geographical region in a clinical trial setting|
DB Henley, SA Dowsett, YF Chen, H Liu-Seifert, JD Grill, RS Doody, ...
Alzheimer's research & therapy 7 (1), 43, 2015